EW vs TRDA · P/E 47, rev $1.39B vs P/E 12, rev $210.8M
Edwards Lifesciences Corp (EW) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the EW and TRDA stock pages for the full models.
Not investment advice.